Most Favored Patient Act of 2026

Key Points

• This bill would limit the amount Medicare and Medicaid pay for many prescription drugs. The price would be capped at the second-lowest price paid for that same drug in a group of eight other countries, including Canada, France, and the United Kingdom.
• The policy would help millions of seniors and low-income Americans by lowering the cost of medications they get at the pharmacy or have administered by a doctor, such as cancer treatments or specialized injections.
• Drug companies could avoid these strict price caps if they sign a special agreement with the government. To do this, they must agree to the lower prices and also commit to creating more manufacturing jobs within the United States.
• This plan is designed to address the fact that Americans often pay significantly more for the exact same medications than people in other wealthy nations.
• If the bill becomes law, the government would start testing this new pricing system on January 1, 2029, and the program would last for five years.